A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

+1

Margaret Shipp and 1 other

Aug 11, 2020

The importance of allelic state in the reporting of TP53 mutations in MDS

Contributor Nature Medicine

Behind the paper

The importance of allelic state in the reporting of TP53 mutations in MDS

Elli Papaemmanuil

Aug 03, 2020

COVID-19 illness severity in patients with cancer

Contributor Nature Medicine

Behind the paper, COVID-19

COVID-19 illness severity in patients with cancer

Mini Kamboj

Jun 24, 2020

Human and artificial intelligence make a great team

Contributor Nature Medicine

Behind the paper

Human and artificial intelligence make a great team

Harald Kittler

Jun 22, 2020

AI, histology and cancer evolution

Contributor Nature Medicine

Behind the paper, TRACERx

AI, histology and cancer evolution

Khalid AbdulJabbar

May 27, 2020

Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer

Contributor Nature Medicine

Behind the paper, TRACERx

Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer

Dr Kroopa Joshi

May 26, 2020

Circulating tumour cells in the pulmonary vein of early stage non small cell lung cancer patients: what do they tell us about risk of relapse after surgery and seeding of metastasis?

Contributor Nature Medicine

Behind the paper, TRACERx

Circulating tumour cells in the pulmonary vein of early stage non small cell lung cancer patients: what do they tell us about risk of relapse after surgery and seeding of metastasis?

Francesca Chemi

May 20, 2020

Circulating tumour cells in the pulmonary vein of early stage non small cell lung cancer patients: what do they tell us about risk of relapse after surgery and seeding of metastasis?

Contributor Nature Medicine

Behind the paper, TRACERx

Circulating tumour cells in the pulmonary vein of early stage non small cell lung cancer patients: what do they tell us about risk of relapse after surgery and seeding of metastasis?

Francesca Chemi

May 20, 2020

Leveraging Cancer Modeling by Enhancing Our Ability to Extrapolate

Contributor Nature Medicine

Behind the paper

Leveraging Cancer Modeling by Enhancing Our Ability to Extrapolate

Chi-Ping Day

Apr 13, 2020

Contributor Nature Medicine

Behind the paper

Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.

In the November issue of Nature Medicine we describe the development of a first-in-class inhibitor of CLCF1 signaling and its effectiveness in several precllinical models of lung adenocarcinoma

Alejandro Sweet-Cordero

Nov 10, 2019

Nature Research Cancer Community

Nature Medicine

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

The importance of allelic state in the reporting of TP53 mutations in MDS

COVID-19 illness severity in patients with cancer

Human and artificial intelligence make a great team

AI, histology and cancer evolution

Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer

Circulating tumour cells in the pulmonary vein of early stage non small cell lung cancer patients: what do they tell us about risk of relapse after surgery and seeding of metastasis?

Circulating tumour cells in the pulmonary vein of early stage non small cell lung cancer patients: what do they tell us about risk of relapse after surgery and seeding of metastasis?

Leveraging Cancer Modeling by Enhancing Our Ability to Extrapolate

Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.

Register to Nature Research Cancer Community